RELIV INTERNATIONAL INC
10-Q/A, EX-27, 2001-01-12
PHARMACEUTICAL PREPARATIONS
Previous: RELIV INTERNATIONAL INC, 10-Q/A, 2001-01-12
Next: RELIV INTERNATIONAL INC, 10-Q/A, 2001-01-12



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FORM 10-Q
FOR THE  QUARTER  ENDING  MARCH 31,  2000 AND IS  QUALIFIED  IN ITS  ENTIRETY BY
REFRENCE TO SUCH FORM 10-Q.
</LEGEND>


<S>                             <C>
<PERIOD-TYPE>                   3-mos
<FISCAL-YEAR-END>                         DEC-31-2000
<PERIOD-START>                            JAN-01-2000
<PERIOD-END>                              MAR-31-2000
<CASH>                                      1,179,531
<SECURITIES>                                        0
<RECEIVABLES>                               1,852,221
<ALLOWANCES>                                  429,000
<INVENTORY>                                 3,917,614
<CURRENT-ASSETS>                            7,949,007
<PP&E>                                     15,404,079
<DEPRECIATION>                              4,815,571
<TOTAL-ASSETS>                             20,157,268
<CURRENT-LIABILITIES>                       7,850,670
<BONDS>                                     4,867,937
                               0
                                         0
<COMMON>                                    9,082,382
<OTHER-SE>                                 (2,281,729)
<TOTAL-LIABILITY-AND-EQUITY>               20,157,268
<SALES>                                    15,088,373
<TOTAL-REVENUES>                           15,088,373
<CGS>                                       6,256,330
<TOTAL-COSTS>                              14,774,295
<OTHER-EXPENSES>                               17,853
<LOSS-PROVISION>                                    0
<INTEREST-EXPENSE>                            154,132
<INCOME-PRETAX>                               142,093
<INCOME-TAX>                                   56,538
<INCOME-CONTINUING>                            85,555
<DISCONTINUED>                                      0
<EXTRAORDINARY>                                     0
<CHANGES>                                           0
<NET-INCOME>                                   85,555
<EPS-BASIC>                                       .01
<EPS-DILUTED>                                     .01



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission